UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.377-386

2021

Volltextzugriff (PDF)

18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.983-993

2016

Volltextzugriff (PDF)

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer

Current treatment options in oncology, 2024-09, Vol.25 (9), p.1225-1237

2024

Volltextzugriff (PDF)

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer

Current treatment options in oncology, 2024-09, Vol.25 (9), p.1210-1224

2024

Volltextzugriff (PDF)

F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.983

2016

Volltextzugriff (PDF)

Distinct tumor protein p53 mutants in breast cancer subgroups

International journal of cancer, 2013-03, Vol.132 (5), p.1227-1231

2013

Volltextzugriff (PDF)

Letter to the Editor: PET/CT in Locally Advanced Breast Cancer: Time for a Guideline Change?

Journal of the National Comprehensive Cancer Network, 2021-08, Vol.19 (8), p.xxx

2021

Volltextzugriff (PDF)

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Oncogene, 2002-10, Vol.21 (49), p.7593-7597

2002

Volltextzugriff (PDF)

Prospects in senology

Soins; la revue de référence infirmière, 2019-12, Vol.64 (841), p.56

2019

Volltextzugriff (PDF)

Perspectives en sénologie

Soins; la revue de référence infirmière, 2019-12, Vol.64 (841), p.56-59

2019

Volltextzugriff (PDF)

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

Breast cancer research : BCR, 2017-01, Vol.19 (1), p.3-3, Article 3

2017

Volltextzugriff (PDF)

Intraoperative Radiotherapy for Breast Cancer in Elderly Women

Clinical breast cancer, 2022-01, Vol.22 (1), p.e109-e113

2022

Volltextzugriff (PDF)

Concomitant medication, comorbidity and survival in patients with breast cancer

Nature communications, 2024-04, Vol.15 (1), p.2966-2966, Article 2966

2024

Volltextzugriff (PDF)

sup 18^F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.983

2016

Volltextzugriff (PDF)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

Oncotarget, 2019-11, Vol.10 (61), p.6577-6588

2019

Volltextzugriff (PDF)

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients

European journal of nuclear medicine and molecular imaging, 2017-07, Vol.44 (7), p.1145-1154

2017

Volltextzugriff (PDF)

Cancer lobulaire infiltrant : épidémiologie, histoire naturelle, principes thérapeutiques

Imagerie de la femme, 2017-10, Vol.27 (3), p.190-196

2017

Volltextzugriff (PDF)

Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie, obstétrique, fertilité & sénologie, 2022-02, Vol.50 (2), p.107

2022

Volltextzugriff (PDF)

The post-cancer period, a conceptual and epidemiological approach

Soins; la revue de référence infirmière, 2014-03 (783), p.26

2014

Volltextzugriff (PDF)

L’après-cancer, approche conceptuelle et épidémiologique

Soins; la revue de référence infirmière, 2014-03, Vol.59 (783), p.26-29

2014

Volltextzugriff (PDF)

2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group

Annals of oncology, 2009-09, Vol.20 (9), p.1459-1471

2009

Volltextzugriff (PDF)

Should FDG PET/CT be used for the initial staging of breast cancer?

European journal of nuclear medicine and molecular imaging, 2009-10, Vol.36 (10), p.1539-1542

2009

Volltextzugriff (PDF)

18 F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

Journal of Nuclear Medicine, 2016-04, Vol.57 (4), p.536-543

2016

Volltextzugriff (PDF)

18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients

Oncotarget, 2018-03, Vol.9 (23), p.16343-16353

2018

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

KollektionNUS Single-Journal Subscriptions

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer

F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial

Distinct tumor protein p53 mutants in breast cancer subgroups

Letter to the Editor: PET/CT in Locally Advanced Breast Cancer: Time for a Guideline Change?

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Prospects in senology

Perspectives en sénologie

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

Intraoperative Radiotherapy for Breast Cancer in Elderly Women

Concomitant medication, comorbidity and survival in patients with breast cancer

sup 18^F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients

Cancer lobulaire infiltrant : épidémiologie, histoire naturelle, principes thérapeutiques

Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

The post-cancer period, a conceptual and epidemiological approach

L’après-cancer, approche conceptuelle et épidémiologique

2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group

Should FDG PET/CT be used for the initial staging of breast cancer?

18 F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients

Aktive Filter

Suchergebnisse filtern